ARGENX SE is 29.8x more valuable than IOVANCE BIOTHERAPEUTICS, INC. by market capitalization ($53.35 B vs $1.79 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | IOVA | ARGX |
|---|---|---|
| Market cap | $1.79 B | $53.35 B |
| US-listed rank | #2183 | #306 |
| Revenue (latest FY) | $263.50M | - |
| Net income (latest FY) | -$391.00M | - |
| Net margin | -148.4% | - |
| SEC filings | 1,005 | 272 |
ARGENX SE is 29.8x more valuable than IOVANCE BIOTHERAPEUTICS, INC. by market capitalization ($53.35 B vs $1.79 B).
Full pages: IOVANCE BIOTHERAPEUTICS, INC. and ARGENX SE, or browse the full rankings.